3,5-Bis(1,1-dimethylethyl)-2-hydroxybenzoic acid
19715-19-6CC(C)(C)c1cc(C(=O)O)c(O)c(C(C)(C)C)c1ZWQBZEFLFSFEOS-UHFFFAOYSA-Nstructure given in first source; RN given refers to parent cpd
19715-19-6Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H302 (97.6%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 41 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Warning
H302: Harmful if swallowed [Warning Acute toxicity, oral]
Acute Tox. 4 (97.6%)
Acute toxicity (Oral) - Category 4
Verwenden3,5-Di-tert-butylsalicylic acid was used to study long wavelength fluorescence emission of 3,5-Di-tert-butylsalicylic acid in a variety of organic solvents. It was also used to catalyze the reaction between aldehydes and silyl ketene acetals.
DTXSID2066519